Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Immune Challenge Study Controlled Exposure to Inhaled Resiquimod (R848) to Study Mechanisms of Inflammation

NCT06488118 is registered in ClinicalTrials.gov with Akhilesh Jha as lead sponsor.

NCT NCT06488118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Immune Challenge Study Controlled Exposure to Inhaled Resiquimod (R848) to Study Mechanisms of Inflammation
Lead sponsor
Akhilesh Jha
Phase
Not applicable
Overall status
Unknown status
Start date
May 24, 2024
Completion date
July 31, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, innate immunity, mucosal immunity, viral infection